ecancer

Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer

Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK

30 Sep 2013

Editor’s Choice - ecancermedicalscience August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

8 Aug 2013

ecancerNews Highlights from August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

8 Aug 2013

Introducing new cervical and breast cancer screening methods

Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India

25 Jul 2013

Cervical cancer prevention in Mozambique

Dr Leonardo Chavane – Jhpiego, Maputo, Mozambique

24 Jul 2013

Role of metronomics in cancer clinical trials and practice in developing countries

Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India

19 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Next generation of anti-cancer agents: data from ASCO 2013

Dr Sarah Blagden - Imperial College, London, UK

4 Jun 2013

Biennial cervical cancer screening with vinegar reduces mortality

Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India

3 Jun 2013

Biennial cervical cancer screening with vinegar reduces mortality

Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India

2 Jun 2013

Comment on biennial visual inspection with acetic acid (VIA), or vinegar

Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA

2 Jun 2013

More from ecancer